The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved about 800 elderly men with low testosterone and symptoms related to this affliction, such anti aging supplement
as physical and sexual dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
Studies have shown that testosterone deficiency is related to a number of important health problems including diabetes, obesity, metabolic syndrome, and bone fractures Men who meet medical criteria for treatment should get therapy. The truth is, your testosterone levels have likely been slowly decreasing for quite some time, a decline that usually starts around age 30.
And many women have a knee jerk suspicion that any hormone treatment
can raise their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will probably stay the status quo for some time, given the prohibitive cost of conducting the long-term safety studies needed to win more total FDA approval.